ID   P3HR-5
AC   CVCL_E9ZN
SY   P3J-HR5
RX   PubMed=5260617;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1317 ! Jiyoye
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=5260617; DOI=10.1093/jnci/43.5.1129;
RA   Huang, Chester C.
RA   Imamura, Tatsuo
RA   Moore, George Eugene
RT   "Chromosomes and cloning efficiencies of hematopoietic cell lines
RT   derived from patients with leukemia, melanoma, myeloma, and Burkitt
RT   lymphoma.";
RL   J. Natl. Cancer Inst. 43:1129-1146(1969).
//